Stéphane Viau

497 total citations
9 papers, 190 citations indexed

About

Stéphane Viau is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Stéphane Viau has authored 9 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Stéphane Viau's work include Phagocytosis and Immune Regulation (2 papers), Microtubule and mitosis dynamics (2 papers) and Berberine and alkaloids research (1 paper). Stéphane Viau is often cited by papers focused on Phagocytosis and Immune Regulation (2 papers), Microtubule and mitosis dynamics (2 papers) and Berberine and alkaloids research (1 paper). Stéphane Viau collaborates with scholars based in Canada and Jordan. Stéphane Viau's co-authors include Aiping Young, Normand Robert, Gisèle LaPointe, Danielle Leblanc, A. Morin, Maria Koutroumanis, Claire G. Cupples, James R. Wright, Raed A. Al‐Qawasmeh and Hongnan Jin and has published in prestigious journals such as Blood, Applied and Environmental Microbiology and Journal of Bacteriology.

In The Last Decade

Stéphane Viau

9 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Viau Canada 6 123 31 28 27 26 9 190
Valentina Piano Germany 9 249 2.0× 21 0.7× 40 1.4× 37 1.4× 15 0.6× 12 366
Chih‐Hsiang Chang Taiwan 13 178 1.4× 18 0.6× 47 1.7× 22 0.8× 54 2.1× 22 347
Carlos A. Martinez United States 8 285 2.3× 24 0.8× 47 1.7× 6 0.2× 17 0.7× 10 361
Jun Fujimoto Japan 10 217 1.8× 17 0.5× 81 2.9× 14 0.5× 27 1.0× 11 333
I‐Ting Chen Taiwan 11 121 1.0× 16 0.5× 69 2.5× 9 0.3× 34 1.3× 22 326
Chen‐Yu Lai Taiwan 9 230 1.9× 13 0.4× 45 1.6× 8 0.3× 21 0.8× 11 323
W. Scott Willett United States 7 298 2.4× 32 1.0× 19 0.7× 12 0.4× 35 1.3× 7 347
Huili Xia China 5 155 1.3× 12 0.4× 7 0.3× 12 0.4× 20 0.8× 8 267
Pei-Jing Pai United States 7 287 2.3× 11 0.4× 45 1.6× 13 0.5× 58 2.2× 8 347
Harshal Khanwalkar France 12 212 1.7× 16 0.5× 105 3.8× 7 0.3× 56 2.2× 14 346

Countries citing papers authored by Stéphane Viau

Since Specialization
Citations

This map shows the geographic impact of Stéphane Viau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Viau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Viau more than expected).

Fields of papers citing papers by Stéphane Viau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Viau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Viau. The network helps show where Stéphane Viau may publish in the future.

Co-authorship network of co-authors of Stéphane Viau

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Viau. A scholar is included among the top collaborators of Stéphane Viau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Viau. Stéphane Viau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Viller, Natasja Nielsen, Emma Linderoth, Lisa D. Johnson, et al.. (2016). Abstract B028: Blockade of the CD47 “Do not eat” signal by TTI-621 (SIRPαFc) leads to enhanced antitumor CD8+ T cell responses in vitro. Cancer Immunology Research. 4(11_Supplement). B028–B028. 1 indexed citations
2.
Uger, Robert A., Xinli Pang, Mark Wong, et al.. (2013). Blockade Of CD47 Using SIRPαFc: Role Of The Fc Region In Anti-Leukemic Activity and Tolerability. Blood. 122(21). 3935–3935. 3 indexed citations
3.
Huesca, Mario, Lisa Lock, Aye Aye Khine, et al.. (2009). A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis. Molecular Cancer Therapeutics. 8(9). 2586–2596. 26 indexed citations
4.
Vassilakos, Aikaterini, Yoon Lee, Stéphane Viau, et al.. (2009). GTI-2040 displays cooperative anti-tumor activity when combined with interferon alpha against human renal carcinoma xenografts.. PubMed. 34(1). 33–42. 2 indexed citations
5.
Al‐Qawasmeh, Raed A., Yoon Lee, Xiaoping Gu, et al.. (2008). 11-Phenyl-[b,e]-dibenzazepine compounds: Novel antitumor agents. Bioorganic & Medicinal Chemistry Letters. 19(1). 104–107. 25 indexed citations
6.
Lee, Yoon, Ningping Feng, Raed A. Al‐Qawasmeh, et al.. (2004). NC381, a Novel Anticancer Agent, Arrests the Cell Cycle in G0-G1 and Inhibits Lung Tumor Cell Growth in Vitro and in Vivo. Journal of Pharmacology and Experimental Therapeutics. 308(2). 538–546. 19 indexed citations
7.
Lee, Yoon Seong, Ningping Feng, Hongnan Jin, et al.. (2003). Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.. PubMed. 9(12). 4553–61. 33 indexed citations
8.
Viau, Stéphane, et al.. (1996). Overexpression of vsr in Escherichia coli is mutagenic. Journal of Bacteriology. 178(14). 4294–4296. 30 indexed citations
9.
LaPointe, Gisèle, Stéphane Viau, Danielle Leblanc, Normand Robert, & A. Morin. (1994). Cloning, sequencing, and expression in Escherichia coli of the D-hydantoinase gene from Pseudomonas putida and distribution of homologous genes in other microorganisms. Applied and Environmental Microbiology. 60(3). 888–895. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026